BIA letter to the Chancellor ahead of the 2019 Spending Round
The BIA has written to the Chancellor ahead of the 2019 Spending Round to highlight how the Government should maintain a competitive life sciences environment in the UK.
In this blog, Richard Turner, Senior Managing Director at FTI Consulting, discusses how licence and collaboration agreements in life sciences can create significant tax consequences.
Cancer Research Horizons adds the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study dataset to its growing portfolio of commercially licensable data assets.
It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.
